Abstract
The purpose of this study is to determine the prevalence of PALB2 mutations among breast cancer families from the United States. The PALB2 gene was screened for mutations in 90 familial breast cancer patients from the Creighton University Breast Cancer Family Registry. These patients had previously tested negative for mutations in BRCA1 and BRCA2. Two of 90 breast cancer patients (2.2 %) were found to carry a truncating mutation in PALB2 (c.2411_2412delCT and c.2053delC). Both probands were diagnosed with breast cancer before age 35 and each had three relatives with breast cancer. Mutations in PALB2 are less common than BRCA1 and BRCA2 in familial breast cancer patients. However, testing for PALB2 mutations is a useful adjunct for patients undergoing testing for BRCA1 and BRCA2.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Casadei S, Norquist BM, Walsh T et al (2011) Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res 71:2222–2229
Fernandes PH, Saam J, Peterson J et al (2014) Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 explains a subset of hereditary breast cancer. Cancer 120:963–967
Nguyen-Dumont T, Hammet F, Mahmoodi M et al (2015) Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry. Breast Cancer Res Treat 149:547–554
Erkko H, Xia B, Nikkila J et al (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316–319
Dansonka-Mieszkowska A, Kluska A, Moes J et al (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Genet 11:20
Southey MC, Teo ZL, Dowty JG et al (2010) A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res 12:109
Antoniou AC, Casadei S, Heikkinen T et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497–506
Sopik V, Narod SA (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:1650
Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25:1754–1760
Picard (2014) http://picard.sourceforge.net. Accessed on 15 Jan 2014
McKenna A, Hanna M, Banks E et al (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297–1303
Zhen DB, Rabe KG, Gallinger S et al (2014) BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. doi:10.1038/gim.2014.153
Jones S, Hruban RH, Kamiyama M et al (2009) Exomic sequencing identifies PALB2 as a pancreatic susceptibility gene. Science 5924:217
Tung N, Battelli C, Allen B et al (2015) Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer 121:25–33
Acknowledgments
We thank Eugene Wong for help with preparing the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Snyder, C., Metcalfe, K., Sopik, V. et al. Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry. Breast Cancer Res Treat 150, 637–641 (2015). https://doi.org/10.1007/s10549-015-3347-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-015-3347-x